Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors.
Ábrányi-Balogh P, Keeley A, Ferenczy GG, Petri L, Imre T, Grabrijan K, Hrast M, Knez D, Ilaš J, Gobec S, Keserű GM. Ábrányi-Balogh P, et al. Among authors: petri l. Pharmaceuticals (Basel). 2022 Nov 29;15(12):1484. doi: 10.3390/ph15121484. Pharmaceuticals (Basel). 2022. PMID: 36558935 Free PMC article.
A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
Ábrányi-Balogh P, Petri L, Imre T, Szijj P, Scarpino A, Hrast M, Mitrović A, Fonovič UP, Németh K, Barreteau H, Roper DI, Horváti K, Ferenczy GG, Kos J, Ilaš J, Gobec S, Keserű GM. Ábrányi-Balogh P, et al. Among authors: petri l. Eur J Med Chem. 2018 Dec 5;160:94-107. doi: 10.1016/j.ejmech.2018.10.010. Epub 2018 Oct 6. Eur J Med Chem. 2018. PMID: 30321804
Covalent fragment libraries in drug discovery.
Keeley A, Petri L, Ábrányi-Balogh P, Keserű GM. Keeley A, et al. Among authors: petri l. Drug Discov Today. 2020 Jun;25(6):983-996. doi: 10.1016/j.drudis.2020.03.016. Epub 2020 Apr 13. Drug Discov Today. 2020. PMID: 32298798 Free article. Review.
Targeting an Intrinsically Disordered Protein by Covalent Modification.
Nguyen HH, Ábrányi-Balogh P, Petri L, Mészáros A, Pauwels K, Vandenbussche G, Keserű GM, Tompa P. Nguyen HH, et al. Among authors: petri l. Methods Mol Biol. 2020;2141:835-854. doi: 10.1007/978-1-0716-0524-0_43. Methods Mol Biol. 2020. PMID: 32696392
Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments.
Petri L, Ábrányi-Balogh P, Tímea I, Pálfy G, Perczel A, Knez D, Hrast M, Gobec M, Sosič I, Nyíri K, Vértessy BG, Jänsch N, Desczyk C, Meyer-Almes FJ, Ogris I, Golič Grdadolnik S, Iacovino LG, Binda C, Gobec S, Keserű GM. Petri L, et al. Chembiochem. 2021 Feb 15;22(4):743-753. doi: 10.1002/cbic.202000700. Epub 2020 Nov 9. Chembiochem. 2021. PMID: 33030752
WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
Scarpino A, Petri L, Knez D, Imre T, Ábrányi-Balogh P, Ferenczy GG, Gobec S, Keserű GM. Scarpino A, et al. Among authors: petri l. J Comput Aided Mol Des. 2021 Feb;35(2):223-244. doi: 10.1007/s10822-020-00371-5. Epub 2021 Jan 18. J Comput Aided Mol Des. 2021. PMID: 33458809 Free PMC article.
Discovery of selective fragment-sized immunoproteasome inhibitors.
Kollár L, Gobec M, Szilágyi B, Proj M, Knez D, Ábrányi-Balogh P, Petri L, Imre T, Bajusz D, Ferenczy GG, Gobec S, Keserű GM, Sosič I. Kollár L, et al. Among authors: petri l. Eur J Med Chem. 2021 Jul 5;219:113455. doi: 10.1016/j.ejmech.2021.113455. Epub 2021 Apr 20. Eur J Med Chem. 2021. PMID: 33894528
40 results